Nasopharyngeal carcinoma: Molecular biomarker discovery and progress

Molecular Cancer

Volumn 6, Issue , 2007, Pages

  Cho, William Chi Shing ^a  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CADHERIN; CELL ADHESION MOLECULE; CERULOPLASMIN; HEAT SHOCK PROTEIN 27; RNA; STATHMIN; TRANSCRIPTION FACTOR; VIRUS DNA;

BIOINFORMATICS; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOGENESIS; DIAGNOSTIC ERROR; DIETARY INTAKE; DISEASE COURSE; DNA DETERMINATION; DRUG TARGETING; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; ETHNICITY; GENE TARGETING; GENOMICS; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; MOLECULAR BIOLOGY; NASOPHARYNX CARCINOMA; PREVALENCE; PROGNOSIS; PROTEOMICS; RARE DISEASE; REVIEW; RNA INTERFERENCE; SENSITIVITY AND SPECIFICITY; SOUTH ASIA; TUMOR BIOPSY;

BIOLOGICAL MARKERS; EPSTEIN-BARR VIRUS INFECTIONS; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; NASOPHARYNGEAL NEOPLASMS; RNA INTERFERENCE; SERUM AMYLOID A PROTEIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

HUMAN HERPESVIRUS 4;

EID: 33846705453     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-6-1     Document Type: Review

References (88)

1. Chien YC Chen JY Liu MY Yang HI Hsu MM Chen CJ Yang CS Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men N Engl J Med 2001 345 1877-1882 10.1056/NEJMoa011610 11756578
2. Tiwawech D Srivatanakul P Karalak A Ishida T Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma Cancer Lett 2005 241 135-141 10.1016/j.canlet.2005.10.026 16377082
3. Jiang J Li Z Su G Jia W Zhang R Yu X Zhang M Wen J Zeng Y Study on genetic polymorphisms of CYP2F1 gene in Guangdong population of China Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006 23 383-387 16883522
4. Cao Y Miao XP Huang MY Deng L Hu LF Ernberg I Zeng YX Lin DX Shao JY Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population BMC Cancer 2006 6 167 1550725 16796765 10.1186/ 1471-2407-6-167
5. Catarino RJ Breda E Coelho V Pinto D Sousa H Lopes C Medeiros R Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma Head Neck 2006 28 603-608 10.1002/hed.20377 16691558
6. Brennan BM Nasopharyngeal carcinoma Orphanet J Rare Dis 2006 1 23 1559589 16800883 10.1186/1750-1172-1-23
7. Shih-Hsin Wu L Construction of evolutionary tree models for nasopharyngeal carcinoma using comparative genomic hybridization data Cancer Genet Cytogenet 2006 168 105-108 10.1016/ j.cancergencyto.2006.02.017 16843099
8. Zeng ZY Qian J Xiong W Zhou YH Zhang WL Li XL Tang K Li WF Li GY Expression and location of UBAP1 protein associated with nasopharyngeal carcinoma Zhong Nan Da Xue Xue Bao Yi Xue Ban 2005 30 621-624 16708796
9. Zeng Z Zhou Y Zhang W Li X Xiong W Liu H Fan S Qian J Wang L Li Z Shen S Li G Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus Genet Med 2006 8 156-160 16540749
10. Chow LS Lam CW Chan SY Tsao SW To KF Tong SF Hung WK Dammann R Huang DP Lo KW Identification of RASSF1A modulated genes in nasopharyngeal carcinoma Oncogene 2006 25 310-316 16116475
11. Zhang SQ Peng H Song LY Li XM Jiang HY Yao KT Zhao T Detection of KIAA1173 gene expression in nasopharyngeal carcinoma tissues and cell lines on tissue microarray Ai Zheng 2005 24 1322-1326 16552956
12. Zeng Z Zhou Y Xiong W Luo X Zhang W Li X Fan S Cao L Tang K Wu M Li G Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray J Cancer Res Clin Oncol 2007 133 71-81 10.1007/s00432-006-0136-2 16941191
13. Wong TS Kwong DL Sham J Wei WI Kwong YL Yuen AP Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma Eur J Surg Oncol 2005 31 555-558 10.1016/j.ejso.2005.01.005 15922893
14. Chen YK Su CT Ding HJ Chi KH Liang JA Shen YY Chen LK Yeh CL Liao AC Kao CH Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients Anticancer Res 2006 26 1471-1477 16619560
15. Abou-Elhamd KE Habib TN The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma Oral Oncol 2006 http://dx.doi.org/doi:10.1016/j.oraloncology.2006.01.007 16931118
16. Wong BC Chan KC Chan AT Leung SF Chan LY Chow KC Lo YM Reduced plasma RNA integrity in nasopharyngeal carcinoma patients Clin Cancer Res 2006 12 2512-2516 10.1158/1078-0432.CCR-05-2572 16638860
17. Sun D Zhang Z Van DN Huang G Ernberg I Hu L Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker Oral Oncol 2006 http://dx.doi.org/doi:10.1016/ j.oraloncology.2006.01.007
18. Wu CC Chien KY Tsang NM Chang KP Hao SP Tsao CH Chang YS Yu JS Cancer cell-secreted proteomes as a basis for searching potential tumour markers: Nasopharyngeal carcinoma as a model Proteomics 2005 5 3173-3182 10.1002/pmic.200401133 16035111
19. Baujat B Audry H Bourhis J Chan AT Onat H Chua DT Kwong DL Al-Sarraf M Chi KH Hareyama M Leung SF Thephamongkhol K Pignon JP MAC-NPC Collaborative Group Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients Int J Radiat Oncol Biol Phys 2006 64 47-56 10.1016/j.ijrobp.2005.06.037 16377415
20. Lee AW Law SC Foo W Poon YF Chan DK O SK Tung SY Cheung FK Thaw M Ho JH Nasopharyngeal carcinoma: Local control by megavoltage irradiation Br J Radiol 1993 66 528-536 8330138
21. Sanguineti G Geara FB Garden AS Tucker SL Ang KK Morrison WH Peters LJ Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control Int J Radiat Oncol Biol Phys 1997 37 985-996 10.1016/S0360-3016(97)00104-1 9169804
22. Jeyakumar A Brickman TM Jeyakumar A Doerr T Review of nasopharyngeal carcinoma Ear Nose Throat J 2006 85 168-170 16615599
23. Lung HL Bangarusamy DK Xie D Cheung AK Cheng Y Kumaran MK Miller L Liu ET Guan XY Sham JS Fang Y Li L Wang N Protopopov AI Zabarovsky ER Tsao SW Stanbridge EJ Lung ML THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma Oncogene 2005 24 6525-6532 16007174
24. Yau WL Lung HL Zabarovsky ER Lerman MI Sham JS Chua DT Tsao SW Stanbridge EJ Lung ML Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma Int J Cancer 2006 119 2821-2826 10.1002/ijc.22232 16929489
25. Peng D Ren CP Yi HM Zhou L Yang XY Li H Yao KT Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma Acta Biochim Biophys Sin (Shanghai) 2006 38 349-355 10.1111/j.1745-7270.2006.00164.x 16680376
26. Ying J Srivastava G Hsieh WS Gao Z Murray P Liao SK Ambinder R Tao Q The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors Clin Cancer Res 2005 11 6442-6449 10.1158/1078-0432.CCR-05-0267 16166418
27. Zhou M Liu H Xu X Zhou H Li X Peng C Shen S Xiong W Ma J Zeng Z Fang S Nie X Yang Y Zhou J Xiang J Cao L Peng S Li S Li G Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression J Cell Biochem 2006 98 920-930 10.1002/jcb.20788 16475162
28. Cheung HW Chun AC Wang Q Deng W Hu L Guan XY Nicholls JM Ling MT Chuan Wong Y Tsao SW Jin DY Wang X Inactivation of human MAD2B in nasopharyngeal carcinoma cells leads to chemosensitization to DNA-damaging agents Cancer Res 2006 66 4357-4367 10.1158/ 0008-5472.CAN-05-3602 16618761
29. Lin YC You L Xu Z He B Mikami I Thung E Chou J Kuchenbecker K Kim J Raz D Yang CT Chen JK Jablons DM Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines Biochem Biophys Res Commun 2006 341 635-640 10.1016/j.bbrc.2005.12.220 16427602
30. Yang H Zhao R Lee MH 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma Mol Cancer Ther 2006 5 253-260 10.1158/1535-7163.MCT-05-0395 16505098
31. He N Kong W The role of EPR-1 in proliferation and apoptosis in nasopharyngeal carcinoma Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005 19 782-784 16334252
32. Kong WJ Zhang S Guo CK Wang YJ Chen X Zhang SL Zhang D Liu Z Kong W Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma Anticancer Drugs 2006 17 251-259 10.1097/00001813-200603000-00003 16520653
33. Lacy J Loomis R Grill S Srimatkandada P Carbone R Cheng YC Systemic bcl-2 antisense oligodeoxynucleotide in combination with cisplatin cures EBV+ nasopharyngeal carcinoma xenografts in SCID mice Int J Cancer 2006 119 309-316 10.1002/ijc.21804 16477627
34. Li JX Zhou KY Cai KR Liang T Tang XD Zhang YF Knockdown of bcl-xL expression with RNA interference induces nasopharyngeal carcinoma cells apoptosis Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2005 40 347-351 16229175
35. Weng DS Wu ZR Wang S Ding YQ Effect of silencing epidermal growth factor receptor expression by RNA interference on the growth of nasopharyngeal carcinoma cell 5-8F Nan Fang Yi Ke Da Xue Xue Bao 2006 26 71-74 16495180
36. Shi W Bastianutto C Li A Perez-Ordonez B Ng R Chow KY Zhang W Jurisica I Lo KW Bayley A Kim J O'sullivan B Siu L Chen E Liu FF Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling Int J Cancer 2006 119 2467-2675 10.1002/ijc.22107 16858677
37. Perez CA Devineni VR Marcial-Vega V Marks JE Simpson JR Kucik N Carcinoma of the nasopharynx: Factors affecting prognosis Int J Radiat Oncol Biol Phys 1992 23 271-280 1587746
38. Geara FB Sanguineti G Tucker SL Garden AS Ang KK Morrison WH Peters LJ Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of distant metastasis and survival Radiother Oncol 1997 43 53-61 10.1016/ S0167-8140(97)01914-2 9165137
39. Shi X Yuan X Tao D Gong J Hu G Analysis of DNA ploidy, cell cycle and Ki67 antigen in nasopharyngeal carcinoma by flow cytometry J Huazhong Univ Sci Technolog Med Sci 2005 25 198-201 16116972
40. Zhao GQ Xu Y Wang Q Significance of serum vascular endothelial growth factor test before radiotherapy in patients with nasopharyngeal carcinoma Zhong Xi Yi Jie He Xue Bao 2005 3 274-277 16009104
41. Mai HQ Zeng ZY Zhang CQ Feng KT Guo X Mo HY Deng MQ Min HQ Hong MH Elevated plasma big ET-1 is associated with distant failure in patients with advanced-stage nasopharyngeal carcinoma Cancer 2006 106 1548-1553 10.1002/cncr.21790 16518816
42. Doustjalali SR Yusof R Govindasamy GK Bustam AZ Pillay B Hashim OH Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression J Med Invest 2006 53 20-28 10.2152/ jmi.53.20 16537992
43. Cho WC Yip TT Yip C Yip V Thulasiraman V Ngan RK Yip TT Lau WH Au JS Law SC Cheng WW Ma VW Lim CK Identification of serum amyloid A protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling Clin Cancer Res 2004 10 43-52 10.1158/ 1078-0432.CCR-0413-3 14734450
44. Cho WC Yip TT Ngan RK Yip TT Podust VN Yip C Yiu HH Yip V Cheng WW Ma VW Law SC ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma Clin Chem 2007 http://dx.doi.org/doi:10.1373/clinchem.2005.065805 17200135
45. Bailet JW Mark RJ Abemayor E Lee SP Tran LM Juillard G Ward PH Nasopharyngeal carcinoma: Treatment results with primary radiation therapy Laryngoscope 1992 102 965-972 1518360
46. Fandi A Altun M Azli N Armand JP Cvitkovic E Nasopharyngeal cancer: epidemiology, staging, and treatment Semin Oncol 1994 21 382-397 8209270
47. Teo PM Chan AT Lee WY Leung TW Johnson PJ Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy Int J Radiat Oncol Biol Phys 1999 43 261-271 10.1016/ S0360-3016(98)00383-6 10030248
48. Cooper JS Scott C Marcial V Griffin T Fazekas J Laramore G Hoffman A The relationship of nasopharyngeal carcinomas and second independent malignancies based on the radiation therapy oncology group experience Cancer 1991 67 1673-1677 10.1002/ 1097-0142(19910315)67:6<1673::AID-CNCR2820670632>3.0.CO;2-1 2001556
49. Mo L Wang H Huang G Zhao H Kuang G Correlation between expression of the Tiam1 gene and the invasion and metastasis in nasopharyngeal carcinoma Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005 19 785-787 16334253
50. Horikawa T Kaizaki Y Kato H Furukawa M Yoshizaki T Expression of interleukin-8 receptor A predicts poor outcome in patients with nasopharyngeal carcinoma Laryngoscope 2005 115 62-67 15630368
51. Mo L Kuang G Luo Y Yang R Relationship between the expression of estrogen and progestrogen receptors in distant metastasis of nasopharyngeal carcinoma Lin Chuang Er Bi Yan Hou Ke Za Zhi 2006 20 494-495 16929828
52. Wang SS Guan ZZ Xiang YQ Wang B Lin TY Jiang WQ Zhang L Zhang HZ Hou JH Significance of EGFR and p-ERK expression in nasopharyngeal carcinoma Zhonghua Zhong Liu Za Zhi 2006 28 28-31 16737616
53. Krishna SM James S Balaram P Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status Virus Res 2006 115 85-90 10.1016/j.virusres.2005.07.010 16139912
54. Sha D He YJ Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma Ai Zheng 2006 25 229-234 16480593
55. Jiang WZ Liao YP Zhao YP Zhao SP Expression clinical significance of nm23-H1 and vessel endothelium growth factor protein in nasopharyngeal carcinoma Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2006 41 200-204 16759016
56. Xiang Y Yao H Wang S Hong M He J Cao S Min H Song E Guo X Prognostic value of survivin and livin in nasopharyngeal carcinoma Laryngoscope 2006 116 126-130 10.1097/01.mlg.0000187392.87904.35 16481824
57. Song LB Zeng MS Liao WT Zhang L Mo HY Liu WL Shao JY Wu QL Li MZ Xia YF Fu LW Huang WL Dimri GP Band V Zeng YX Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells Cancer Res 2006 66 6225-6232 10.1158/ 0008-5472.CAN-06-0094 16778197
58. Bar-Sela G Kaplan-Cohen V Ilan N Vlodavsky I Ben-Izhak O Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival Histopathology 2006 49 188-193 10.1111/j.1365-2559.2006.02469.x 16879396
59. Tsang CW Lin X Gudgeon NH Taylor GS Jia H Hui EP Chan AT Lin CK Rickinson AB CD4+ T-cell responses to Epstein-Barr virus nuclear antigen EBNA-1 in Chinese populations are highly focused on novel C-terminal domain-derived epitopes J Virol 2006 80 8263-8266 1563796 16873282 10.1128/JVI.00400-06
60. Fachiroh J Paramita DK Hariwiyanto B Harijadi A Dahlia HL Indrasari SR Kusumo H Zeng YS Schouten T Mubarika S Middeldorp JM Single-assay combination of Epstein-Barr virus (EBV) EBNA-1 and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: Options for field screening J Clin Microbiol 2006 44 1459-1467 1448657 16597877 10.1128/ JCM.44.4.1459-1467.2006
61. Wong MM Lye MS Cheng HM Sam CK Epstein-Barr virus serology in the diagnosis of nasopharyngeal carcinoma Asian Pac J Allergy Immunol 2005 23 65-67 15997877
62. Ho DW Yang ZF Wong BY Kwong DL Sham JS Wei WI Yuen AP Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma Cancer 2006 107 99-107 10.1002/cncr.21970 16708360
63. Guo C Pan ZG Li DJ Yun JP Zheng MZ Hu ZY Cheng LZ Zeng YX The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection J Transl Med 2006 4 23 1525203 16729897 10.1186/1479-5876-4-23
64. Jiang LN Dai LC He JF Chen YW Ma ZH [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients] Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2006 20 2 30-32
65. Neel HB 3rd Pearson GR Taylor WF Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups Ann Otol Rhinol Laryngol 1984 93 477-482 6093669
66. Lin JC Chen KY Wang WY Jan JS Liang WM Tsai CS Wei YH Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma: Relationship to distant metastasis and survival J Clin Oncol 2001 19 2607-2615 11352952
67. Chan KC Lo YM Clinical applications of plasma Epstein-Barr virus DNA analysis and protocols for the quantitative analysis of the size of circulating Epstein-Barr virus DNA Methods Mol Biol 2006 336 111-121 16916257
68. Shao JY Zhang Y Li YH Gao HY Feng HX Wu QL Cui NJ Cheng G Hu B Hu LF Ernberg I Zeng YX Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma Anticancer Res 2004 24 4059-4066 15736452
69. Jiang W Liao Y The dynamic study between EBV DNA with nasopharyngeal carcinoma Lin Chuang Er Bi Yan Hou Ke Za Zhi 2005 19 920 922 16398045
70. Hou X Zhang L Zhao C Li S Lu LX Han F Shao JY Huang PY Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma Ai Zheng 2006 25 785-792 16831265
71. Tan EL Looi LM Sam CK Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma Singapore Med J 2006 47 803-807 16924363
72. Ngan RK Lau WH Yip TT Cho WC Cheng WW Lim CK Wan KK Chu E Joab I Grunewald V Poon YF Ho JH Remarkable application of serum EBV EBER-1 in monitoring response of nasopharyngeal cancer patients to salvage chemotherapy Ann N Y Acad Sci 2001 945 73-79 11708497
73. Fan SQ Ma J Zhou J Xiong W Xiao BY Zhang WL Tan C Li XL Shen SR Zhou M Zhang QH Ou YJ Zhuo HD Fan S Zhou YH Li GY Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis Hum Pathol 2006 37 593-605 10.1016/j.humpath.2006.01.010 16647958
74. Tarbouriech N Ruggiero F de Turenne-Tessier M Ooka T Burmeister WP Structure of the Epstein-Barr virus oncogene BARF1 J Mol Biol 2006 359 667-678 10.1016/j.jmb.2006.03.056 16647084
75. Stevens SJ Verkuijlen SA Hariwiyanto B Harijadi Paramita DK Fachiroh J Adham M Tan IB Haryana SM Middeldorp JM Noninvasive diagnosis of nasopharyngeal carcinoma: Nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA Int J Cancer 2006 119 608-614 10.1002/ijc.21914 16572427
76. Lo AK Lo KW Tsao SW Wong HL Hui JW To KF Hayward DS Chui YL Lau YL Takada K Huang DP Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells Neoplasia 2006 8 173 180 1578522 16611410 10.1593/neo.05625
77. Sengupta S den Boon JA Chen IH Newton MA Dahl DB Chen M Cheng YJ Westra WH Chen CJ Hildesheim A Sugden B Ahlquist P Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma Cancer Res 2006 66 7999-8006 10.1158/ 0008-5472.CAN-05-4399 16912175
78. Mainou BA Raab-Traub N LMP-1 strain variants: Biological and molecular properties J Virol 2006 80 6458-6468 1488979 16775333 10.1128/ JVI.00135-06
79. Yan G Li L Tao Y Liu S Liu Y Luo W Wu Y Tang M Dong Z Cao Y Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein-1 using functional proteomics technology Proteomics 2006 6 1810-1821 10.1002/pmic.200500156 16470631
80. Kim HS Kim JS Kim JS Park JT Lee MC Juhng SW Cho JH Park CS The association between CD99 and LMP-1 expression in nasopharyngeal carcinoma Exp Oncol 2006 28 40 43 16614706
81. Du CW Wen BG Li DR Lin YC Zheng YW Chen L Chen JY Lin W Wu MY Latent membrane protein-1 of Epstein-Barr virus increases sensitivity to arsenic trioxide-induced apoptosis in nasopharyngeal carcinoma cell Exp Oncol 2005 27 267-272 16404345
82. Du C Wen B Li D Lin Y Zheng Y Peng X Hong C Chen J Lin W Hong X Xie L Wu M Downregulation of Epstein-Barr virus-encoded latent membrane protein-1 by arsenic trioxide in nasopharyngeal carcinoma cells Tumori 2006 92 140-148 16724694
83. Du CW Wen BG Li DR Peng X Hong CQ Chen JY Lin ZZ Hong X Lin YC Xie LX Wu MY Zhang H Arsenic trioxide reduces the invasive and metastatic properties of nasopharyngeal carcinoma cells in vitro Braz J Med Biol Res 2006 39 677-685 10.1590/S0100-879X2006000500015 16648906
84. Xie Y, Huang G, Zhang Z, Wen W, Wu Y, Wei Z: Application of EB virus latent membrane protein-1 in nasopharyngeal swab in diagnosis of nasopharyngeal carcinoma. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2006, 20:499-501.
85. Hao SP, Tsang NM, Chang KP, Ueng SH: Molecular diagnosis of nasopharyngeal carcinoma: Detecting LMP-1 and EBNA by nasopharyngeal swab. Otolaryngol Head Neck Surg 2004, 131:651-654.
86. Li G, Li XP, Peng Y, Liu X, Li XH: Effective inhibition of EB virusencoded latent membrane protein-1 by siRNA in EB virus (+) nasopharyngeal carcinoma cell. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2005, 40:406-410.
87. Li X, Liu X, Li CY, Ding Y, Chau D, Li G, Kung HF, Lin MC, Peng Y: Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1. Int J Oncol 2006, 29:595-603.
88. Cho WC: Research progress in SELDI-TOF MS and its clinical applications. Sheng Wu Gong Cheng Xue Bao 2006, 22:871-876.